ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial

Journal article

Open access

J. Lee, A. Dean, T. Price, K. Sjoquist, V. Gebski, J. Mumford, F. Day, S. Yip, K. Wilson, C. Jackson, …

ESMO Gastrointestinal Oncology, Vol.1, pp.3-8

10/2023

Handle:

https://hdl.handle.net/10523/40907

Files and links (1)

url

https://doi.org/10.1016/j.esmogo.2023.07.001View

Published (Version of record) Open

12 Record Views

Record Identifier: 9926556038101891
Title: ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial
Creators: J. Lee
A. Dean
T. Price
K. Sjoquist
V. Gebski
J. Mumford
F. Day
S. Yip
K. Wilson
C. Jackson
S. Padinharakam
B. Lee
M. Burge
D. Siu
C. Karapetis
L. Chantrill
Z.W. Wong
R. Jennens
C. Lomma
A. Franscesconi
S. Ackland
J. Lynam
S. Wahlroos
J. So
M. Jameson
N. Tebbutt
S. Gill
D. Grimes
C. Steer
M. Harris
Publication Details: ESMO Gastrointestinal Oncology, Vol.1, pp.3-8
Academic Unit: Medicine (DSM)
Date published ; e-published: 10/2023
Language: English
Resource Type ; Subtype: Journal article